U.S. patent application number 14/652228 was filed with the patent office on 2015-12-10 for treatment profiles.
The applicant listed for this patent is GAMBRO LUNDIA AB. Invention is credited to John O'MAHONY, Andrew WENGER.
Application Number | 20150355789 14/652228 |
Document ID | / |
Family ID | 49956374 |
Filed Date | 2015-12-10 |
United States Patent
Application |
20150355789 |
Kind Code |
A1 |
O'MAHONY; John ; et
al. |
December 10, 2015 |
TREATMENT PROFILES
Abstract
Extracorporeal blood treatment systems and methods to use and
modify/create treatment profiles for extracorporeal blood
treatments. For example, treatment profiles may include one or more
preset, or predefined, settings or values for an extracorporeal
blood treatment such as, e.g., therapy type, therapy set (e.g.,
tubing set, filter set, etc.), anticoagulation type, and one or
more flow rates, etc.
Inventors: |
O'MAHONY; John; (Maple
Grove, MN) ; WENGER; Andrew; (Osseo, MN) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
GAMBRO LUNDIA AB |
Lund |
|
SE |
|
|
Family ID: |
49956374 |
Appl. No.: |
14/652228 |
Filed: |
December 17, 2013 |
PCT Filed: |
December 17, 2013 |
PCT NO: |
PCT/US2013/075656 |
371 Date: |
June 15, 2015 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
61747852 |
Dec 31, 2012 |
|
|
|
Current U.S.
Class: |
715/810 |
Current CPC
Class: |
G06F 3/0482 20130101;
G16H 20/40 20180101; G06F 3/04842 20130101; G16H 40/63 20180101;
G06F 19/32 20130101 |
International
Class: |
G06F 3/0482 20060101
G06F003/0482; G06F 19/00 20060101 G06F019/00; G06F 3/0484 20060101
G06F003/0484 |
Claims
1. An extracorporeal blood treatment system comprising: a display
apparatus comprising a graphical user interface, wherein the
graphical user interface is configured to depict a profile
identifier region, a therapy type region, and a therapy set region;
an input apparatus configured to allow a user to select a profile
using the profile identifier region of the graphical user
interface; and a computing apparatus operatively coupled to the
display apparatus and the input apparatus, wherein the computing
apparatus is configured to: store a plurality of profiles, wherein
each profile of the plurality of profiles comprises a preset
therapy type of a plurality of different therapy types and a preset
therapy set of a plurality of different therapy sets, allow a user
to use the input apparatus to select a profile of the plurality of
profiles using a profile identifier region of a graphical user
interface, and display on the graphical user interface the preset
therapy type of the selected profile in a therapy type region and
the preset therapy set of the selected profile in a therapy set
region.
2. A method for an extracorporeal blood treatment system
comprising: storing a plurality of profiles, wherein each profile
of the plurality of profiles comprises at least a preset therapy
type of a plurality of different therapy types and a preset therapy
set of a plurality of different therapy sets; providing a graphical
user interface comprising a profile identifier region, a therapy
type region, and a therapy set region; providing an input apparatus
configured to allow a user to select a profile of the plurality of
profiles using the profile identifier region of the graphical user
interface; allowing a user to use the input apparatus to select a
profile of the plurality of profiles using the profile identifier
region of the graphical user interface; and displaying on the
graphical user interface the preset therapy type of the selected
profile in the therapy type region and the preset therapy set of
the selected profile in the therapy set region.
3. The system of claim 1, wherein the plurality of different
therapy types comprises at least one of SCUF, CVVH, CVVHD, CVVHDF,
TPE, HP, MARS, and carbon dioxide removal.
4. The system of claim 1, wherein each profile of the plurality of
profiles further comprises an identifier, wherein the computing
apparatus is further configured to execute: displaying the
identifier of each of the plurality of profiles; and allowing a
user to use the input apparatus to select a profile of the
plurality of profiles by selecting the identifier of the
profile.
5. The system of claim 1, wherein the graphical user interface is
further configured to depict a profile filter region, wherein each
profile of the plurality of profiles further comprises
identification data, wherein the computing apparatus is further
configured to execute: allowing a user to use the input apparatus
to select one or more filters using the profile filter region; and
displaying on the graphical user interface one or more profiles of
the plurality of profiles based on the one or more selected
filters.
6. The system of claim 5, wherein the identification data comprises
one or more of prescribing doctor, weight, age, gender disease
state, location, patient identifier, and intracellular volume.
7. The system of claim 1, wherein the computing apparatus is
further configured to execute allowing a user to use the input
apparatus to select at least one of a different therapy type of the
plurality of different therapy types than the preset therapy type
of the selected profile using the therapy type region of the
graphical user interface and a different therapy set of the
plurality of different therapy sets than the preset therapy set of
the selected profile using the therapy set region of the graphical
user interface.
8. The system of claim 1, wherein the computing apparatus is
further configured to execute allowing a user to use the input
apparatus, without selecting a profile of the plurality of
profiles, to select at least one of a therapy type of the plurality
of different therapy types using the therapy type region of the
graphical user interface and a therapy set of the plurality of
different therapy sets using the therapy set region of the
graphical user interface.
9. The system of claim 1, wherein the graphical user interface is
further configured to depict an anticoagulation region, wherein
each profile of the plurality of profiles further comprises a
preset anticoagulation type of a plurality of different types of
anticoagulation, wherein the computing apparatus is further
configured to execute displaying on the graphical user interface
the preset anticoagulation type of the selected profile in an
anticoagulation region of the graphical user interface.
10. The system of claim 9, wherein the computing apparatus is
further configured to execute allowing a user to use the input
apparatus to select a different anticoagulation type of the
plurality of different types of anticoagulation than the present
anticoagulation type using the anticoagulation region of the
graphical user interface.
11. The system of claim 1, wherein each profile of the plurality of
profiles further comprises a preset value for at least one flow
rate of a plurality of flow rates, wherein the graphical user
interface is further configured to depict a flow rate region,
wherein the computing apparatus is further configured to execute
displaying on the graphical user interface the preset value of the
at least one flow rate of the selected profile in a flow rate
region.
12. The system of claim 11, wherein the computing apparatus is
further configured to execute: allowing a user to use the input
apparatus to adjust the preset value of the at least one flow rate
using flow rate region; and displaying on the graphical user
interface an indication proximate the adjusted preset value of the
at least one flow rate in the flow rate region.
13. The system of claim 1, wherein each profile of the plurality of
profiles further comprises at least one preset alarm value for at
least one alarm limit of a plurality of alarm limits, wherein the
graphical user interface is further configured to depict an alarm
region, wherein the computing apparatus is further configured to
execute: displaying the at least one preset alarm value for at
least one alarm limit of the selected profile in an alarm region on
the graphical user interface; and allowing a user to use the input
apparatus to adjust the at least one preset alarm value of the at
least one alarm limit of the plurality of alarm limits of the
selected profile using the alarm region of the graphical user
interface.
14. The system of claim 1, wherein each profile of the plurality of
profiles further comprises at least one preset anticoagulation
value for at least one anticoagulation advisory of a plurality of
anticoagulation advisories, wherein the graphical user interface is
further configured to depict an anticoagulation advisory region,
wherein the computing apparatus is further configured to execute:
displaying the at least one preset anticoagulation value for the at
least one anticoagulation advisory of the plurality of
anticoagulation advisories of the selected profile in an
anticoagulation advisory region on the graphical user interface;
and allowing a user to use the input apparatus to adjust the at
least one preset anticoagulation value of at least one
anticoagulation advisory of the plurality of anticoagulation
advisories of the selected profile using the anticoagulation
advisory region of the graphical user interface.
15. The system of claim 1, wherein the input apparatus comprises a
touch screen.
16. An extracorporeal blood treatment system comprising: a display
apparatus comprising a graphical user interface, wherein the
graphical user interface is configured to depict a profile
identifier region, a therapy type region, and a therapy set region;
an input apparatus configured to allow a user to create a profile
identifier using the profile identifier region of the graphical
user interface, to select a therapy type using the therapy type
region of the graphical user interface, and to select a therapy set
using the therapy set region of the graphical user interface; and a
computing apparatus operatively coupled to the display apparatus
and the input apparatus, wherein the computing apparatus is
configured to: store a plurality of profiles, wherein each profile
of the plurality of profiles comprises an identifier, at least a
preset therapy type of a plurality of different therapy types, and
a preset therapy set of a plurality of different therapy sets,
display a profile identifier region, a therapy type region and a
therapy set region on the graphical user interface, allow a user to
use the input apparatus to enter an identifier for a new profile of
the plurality of profiles using the profile identifier region, to
select a therapy type of the plurality of different therapy types
to be the preset therapy type of the new profile using the therapy
type region of the graphical user interface, and to select a
therapy set of the plurality of different therapy sets to be the
preset therapy set of the new profile using the therapy set region
of the graphical user interface, and allow a user to save the new
profile into the plurality of stored profiles.
17. A method for an extracorporeal blood treatment system
comprising: providing a graphical user interface comprising a
profile identifier region, a therapy type region, and a therapy set
region; providing an input apparatus configured to allow a user to
create or edit a profile identifier using the profile identifier
region of the graphical user interface, to select a therapy type
using the therapy type region of the graphical user interface, and
to select a therapy set using the therapy set region of the
graphical user interface; storing a plurality of profiles, wherein
each profile of the plurality of profiles comprises an identifier,
at least a preset therapy type of a plurality of different therapy
types, and a preset therapy set of a plurality of different therapy
sets; allowing a user to use the input apparatus to enter an
identifier for a new profile of the plurality of profiles using the
profile identifier region of the graphical user interface, to
select a therapy type of the plurality of different therapy types
to be the preset therapy type of the new profile using the therapy
type region of the graphical user interface, and to select a
therapy set of the plurality of different therapy sets to be the
preset therapy set of the new profile using the therapy set region
of the graphical user interface; and allow a user to save the new
profile into the plurality of stored profiles.
18. An extracorporeal blood treatment system comprising: a display
apparatus comprising a graphical user interface, wherein the
graphical user interface is configured to depict a profile
identifier region, a profile selection region, a therapy type
region, and a therapy set region; an input apparatus configured to
allow a user to edit a profile identifier using the profile
identifier region of the graphical user interface, to select a
profile using the profile selection region, to select a therapy
type using the therapy type region of the graphical user interface,
and to select a therapy set using the therapy set region of the
graphical user interface; and a computing apparatus operatively
coupled to the display apparatus and the input apparatus, wherein
the computing apparatus is configured to: store a plurality of
profiles, wherein each profile of the plurality of profiles
comprises an identifier, at least a preset therapy type of a
plurality of different therapy types, and a preset therapy set of a
plurality of different therapy sets, display a profile identifier
region, a profile selection region, a therapy type region, and a
therapy set region on the graphical user interface, allow a user to
use the input apparatus to select a profile of the plurality of
profiles using the profile selection region of the graphical user
interface, display on the graphical user interface the identifier
of the selected profile in the profile identifier region, the
preset therapy type of the selected profile in the therapy type
region, and the preset therapy set of the selected profile in the
therapy set region, allow a user to use the input apparatus to
modify at least one of the preset therapy type of the selected
profile to a different therapy type of the plurality of different
therapy types using the therapy type region of the graphical user
interface and the preset therapy set of the selected profile to a
different therapy set of the plurality of different therapy sets
using the therapy set region of the graphical user interface, and
allow a user to save the modified profile into the plurality of
stored profiles.
19. A method for an extracorporeal blood treatment system
comprising: providing a graphical user interface comprising a
profile identifier region, a profile selection region, a therapy
type region, and a therapy set region; providing an input apparatus
configured to allow a user to create or edit a profile identifier
using the profile identifier region of the graphical user
interface, to select a therapy type using the therapy type region
of the graphical user interface, and to select a therapy set using
the therapy set region of the graphical user interface; and storing
a plurality of profiles, wherein each profile of the plurality of
profiles comprises an identifier, at least a preset therapy type of
a plurality of different therapy types, and a preset therapy set of
a plurality of different therapy sets; displaying a profile
identifier region, a profile selection region, a therapy type
region, and a therapy set region on the graphical user interface;
allowing a user to use the input apparatus to select a profile of
the plurality of profiles using the profile selection region of the
graphical user interface; displaying on the graphical user
interface the identifier of the selected profile in the profile
identifier region, the preset therapy type of the selected profile
in the therapy region, and the preset therapy set of the selected
profile in the therapy set region; allowing a user to use the input
apparatus to modify at least one of the preset therapy type of the
selected profile to a different therapy type of the plurality of
different therapy types using the therapy type region of the
graphical user interface and the preset therapy set of the selected
profile to a different therapy set of the plurality of different
therapy sets using the therapy set region of the graphical user
interface; and allowing a user to save the modified profile into
the plurality of stored profiles.
20. The system of claim 16, wherein the plurality of different
therapy types comprises one or more of SCUF, CVVH, CVVHD, CVVHDF,
TPE, HP, MARS, and carbon dioxide removal.
21. The system of claim 16, wherein the graphical user interface is
further configured to depict an anticoagulation region, wherein
each profile of the plurality of profiles further comprises a
preset anticoagulation type of a plurality of different types of
anticoagulation, wherein the computing apparatus is further
configured to execute: displaying an anticoagulation region on the
graphical user interface; and allowing a user to use the input
apparatus to select an anticoagulation type to be the preset
anticoagulation type of the new profile using the anticoagulation
region of the graphical user interface.
22. The system of claim 16, wherein the computing apparatus is
further configured to execute allowing a user to use the input
apparatus to modify the identifier of the new profile using the
profile identifier region.
23. The system of claim 16, wherein the computing apparatus is
further configured to execute allowing a user to save the new
profile into the plurality of stored profiles if at least a therapy
type and a therapy set has been selected.
24. The system of claim 16, wherein each profile of the plurality
of profiles further comprises a preset value for at least one flow
rate of a plurality of flow rates, wherein the graphical user
interface is further configured to depict a flow rate region,
wherein the computing apparatus is further configured to execute:
displaying a flow rate region on the graphical user interface; and
allowing a user to use the input apparatus to adjust the preset
value of the at least one flow rate of the new profile using the
flow rate region of the graphical user interface.
25. The system of claim 24, wherein the computing apparatus is
further configured to execute displaying on the graphical user
interface an indication proximate the adjusted preset value of the
at least one flow rate in the flow rate region.
26. The system of claim 16, wherein each profile of the plurality
of profiles further comprises at least one preset alarm value for
at least one alarm limit of a plurality of alarm limits, wherein
the graphical user interface is further configured to depict an
alarm region, wherein the computing apparatus is further configured
to execute: displaying an alarm region on the graphical user
interface; and allowing a user to use the input apparatus to adjust
at least one preset alarm value of the plurality of alarm limits of
the new profile using the alarm region of the graphical user
interface.
27. The system of claim 16, wherein each profile of the plurality
of profiles further comprises at least one preset anticoagulation
value for at least one anticoagulation advisory of a plurality of
anticoagulation advisories, wherein the graphical user interface is
further configured to depict an anticoagulation advisory region,
wherein the computing apparatus is further configured to execute:
displaying an anticoagulation advisory region on the graphical user
interface; and allowing a user to use the input apparatus to adjust
at least one preset anticoagulation value of the plurality of the
plurality anticoagulation advisories of the new profile using the
anticoagulation advisory region of the graphical user
interface.
28. The system of claim 16, wherein the input apparatus comprises a
touch screen.
29. The system of claim 16, wherein the computing apparatus is
further configured to execute allowing a user to use the input
apparatus to transfer at least one profile of the plurality of
profiles to an external device.
30. The system of claim 16, wherein the graphical user interface is
further configured to depict a profile selection region comprising
a list of the identifiers of the plurality of profiles, wherein the
computing apparatus is further configured to execute: displaying a
profile selection region on the graphical user interface; and
allowing a user to use the input apparatus to select a profile of
the plurality of profiles using the profile selection region of the
graphical user interface.
31. The system of claim 18, wherein the plurality of profiles
comprise at least one protected profile, wherein at least one of
the identifier, preset therapy type, and preset therapy set of the
at least one protected profile are not modifiable by a user.
32. An extracorporeal blood treatment system comprising: a display
apparatus comprising a graphical user interface, wherein the
graphical user interface is configured to depict a profile
selection interface and a profile creation/modification interface;
an input apparatus configured to allow a user to select, create,
and modify one or more profiles; and a computing apparatus
operatively coupled to the display apparatus and the input
apparatus, wherein the computing apparatus is configured to: store
a plurality of profiles, wherein each profile of the plurality of
profiles comprises an identifier, at least a preset therapy type of
a plurality of different therapy types, and a preset therapy set of
a plurality of different therapy sets; display on the graphical
user interface a profile selection interface configured to allow a
user to select a profile for use in a treatment; and display on the
graphical user interface a profile creation/modification interface
configured to allow a user to modify one or more profiles of the
plurality of profiles and/or to allow a user to create one or more
profiles to be stored in the plurality of profiles
33. A method for an extracorporeal blood treatment system
comprising: providing a graphical user interface, wherein the
graphical user interface is configured to depict a profile
selection interface and a profile creation/modification interface;
providing an input apparatus configured to allow a user to select,
create, and modify one or more profiles; storing a plurality of
profiles, wherein each profile of the plurality of profiles
comprises an identifier, at least a preset therapy type of a
plurality of different therapy types, and a preset therapy set of a
plurality of different therapy sets; and displaying on the
graphical user interface a profile selection interface configured
to allow a user to select a profile for use in a treatment; and
displaying on the graphical user interface a profile
creation/modification interface configured to allow a user to
modify one or more profiles of the plurality of profiles and/or to
allow a user to create one or more profiles to be stored in the
plurality of profiles.
34. The system of claim 32, wherein the profile selection interface
and the profile creation/modification interface are not displayed
at the same time.
Description
CROSS-REFERENCE
[0001] This application claims the benefit of U.S. Provisional
Application Ser. No. 61/747,852, filed Dec. 31, 2012, which is
incorporated herein by reference.
BACKGROUND
[0002] The disclosure herein relates to extracorporeal blood
treatment. More particularly, the disclosure relates to user
interfaces for the selection and/or modification of treatment
profiles for extracorporeal blood treatment.
[0003] Many different settings and/or parameters are selected by a
user, e.g., a clinician, when preparing an extracorporeal blood
treatment for a patient. For example, the therapy type,
anticoagulation type, therapy set (e.g., filter set, tubing set,
etc.), etc. may be selected and/or configured by a clinician prior
to the start of the treatment.
SUMMARY
[0004] The present disclosure describes systems and methods that
provide for selection, creation, and/or modification of profiles
for an extracorporeal blood treatment. Each profile may include a
number of presets (e.g., preset settings, preset values, preset
types, etc.) for one or more different settings for use in an
extracorporeal blood treatment. When preparing an extracorporeal
blood treatment system for treatment of a patient, a user may
select a profile, and the system may be configured according to the
selected profile. After a profile has been selected, a user may
change or modify one or more of the preset settings before
beginning the treatment. Additionally, the exemplary methods and
systems described herein may allow a user to create and/or modify
profiles for future use. Further exemplary methods and systems
described herein may allow a user to copy one or more profiles
between extracorporeal blood treatment systems.
[0005] One exemplary extracorporeal blood treatment system may
include a display apparatus, input apparatus (e.g., a touch screen,
etc.), and computing apparatus. The display apparatus may include a
graphical user interface, where the graphical user interface is
configured to depict a profile identifier region, a therapy type
region, and a therapy set region. The input apparatus may be
configured to allow a user to select a profile using the profile
identifier region of the graphical user interface. The computing
apparatus may be operatively coupled to the display apparatus and
the input apparatus. The computing apparatus may be configured to
store a plurality of profiles, where each profile of the plurality
of profiles may include a preset therapy type of a plurality of
different therapy types (e.g., SCUF, CVVH, CVVHD, CVVHDF, TPE, HP,
MARS, and carbon dioxide removal) and a preset therapy set of a
plurality of different therapy sets. The computing apparatus may be
configured to allow a user to use the input apparatus to select a
profile of the plurality of profiles using a profile identifier
region of a graphical user interface and display on the graphical
user interface the preset therapy type of the selected profile in a
therapy type region and the preset therapy set of the selected
profile in a therapy set region.
[0006] One exemplary method for an extracorporeal blood treatment
system may include storing a plurality of profiles, where each
profile of the plurality of profiles may include at least a preset
therapy type of a plurality of different therapy types (e.g., SCUF,
CVVH, CVVHD, CVVHDF, TPE, HP, MARS, and carbon dioxide removal) and
a preset therapy set of a plurality of different therapy sets,
providing a graphical user interface including a profile identifier
region, a therapy type region, and a therapy set region, providing
an input apparatus (e.g., a touch screen, etc.) configured to allow
a user to select a profile of the plurality of profiles using the
profile identifier region of the graphical user interface, allowing
a user to use the input apparatus to select a profile of the
plurality of profiles using the profile identifier region of the
graphical user interface, and displaying on the graphical user
interface the preset therapy type of the selected profile in the
therapy type region and the preset therapy set of the selected
profile in the therapy set region.
[0007] In one or more exemplary embodiments, each profile of the
plurality of profiles may further include an identifier and the
computing apparatus may be further configured to execute or the
method may further include displaying the identifier of each of the
plurality of profiles and allowing a user to use the input
apparatus to select a profile of the plurality of profiles by
selecting the identifier of the profile.
[0008] In one or more exemplary embodiments, the graphical user
interface is further configured to depict a profile filter region
and each profile of the plurality of profiles further includes
identification data (e.g., prescribing doctor, weight, age, gender
disease state, location, patient identifier, and intracellular
volume). The computing apparatus may be further configured to
execute or the method may further include allowing a user to use
the input apparatus to select one or more filters using the profile
filter region and displaying on the graphical user interface one or
more profiles of the plurality of profiles based on the one or more
selected filters.
[0009] In one or more exemplary embodiments, the computing
apparatus is further configured to execute or the method may
further include allowing a user to use the input apparatus to
select at least one of a different therapy type of the plurality of
different therapy types than the preset therapy type of the
selected profile using the therapy type region of the graphical
user interface and/or a different therapy set of the plurality of
different therapy sets than the preset therapy set of the selected
profile using the therapy set region of the graphical user
interface.
[0010] In one or more exemplary embodiments, the computing
apparatus is further configured to execute or the method may
further include allowing a user to use the input apparatus, without
selecting a profile of the plurality of profiles, to select at
least one of a therapy type of the plurality of different therapy
types using the therapy type region of the graphical user interface
and a therapy set of the plurality of different therapy sets using
the therapy set region of the graphical user interface.
[0011] In one or more exemplary embodiments, the graphical user
interface may be further configured to depict an anticoagulation
region and each profile of the plurality of profiles further may
include a preset anticoagulation type of a plurality of different
types of anticoagulation. The computing apparatus may be further
configured to execute or the method may further include displaying
on the graphical user interface the preset anticoagulation type of
the selected profile in an anticoagulation region of the graphical
user interface. In at least one embodiment, the computing apparatus
may be further configured to execute or the method may further
include allowing a user to use the input apparatus to select a
different anticoagulation type of the plurality of different types
of anticoagulation than the present anticoagulation type using the
anticoagulation region of the graphical user interface.
[0012] In one or more exemplary embodiments, each profile of the
plurality of profiles further may include a preset value for at
least one flow rate of a plurality of flow rates and the graphical
user interface may be further configured to depict a flow rate
region. The computing apparatus may be further configured to
execute or the method may further include displaying on the
graphical user interface the preset value of the at least one flow
rate of the selected profile in a flow rate region. In at least one
embodiment, the computing apparatus may be further configured to
execute or the method may include allowing a user to use the input
apparatus to adjust the preset value of the at least one flow rate
using flow rate region and displaying on the graphical user
interface an indication proximate the adjusted preset value of the
at least one flow rate in the flow rate region.
[0013] In one or more exemplary embodiments, each profile of the
plurality of profiles may further include at least one preset alarm
value for at least one alarm limit of a plurality of alarm limits
and the graphical user interface may be further configured to
depict an alarm region. The computing apparatus may be further
configured to execute or the method may further include displaying
the at least one preset alarm value for at least one alarm limit of
the selected profile in an alarm region on the graphical user
interface and allowing a user to use the input apparatus to adjust
the at least one preset alarm value of the at least one alarm limit
of the plurality of alarm limits of the selected profile using the
alarm region of the graphical user interface.
[0014] In one or more exemplary embodiments, each profile of the
plurality of profiles may further include at least one preset
anticoagulation value for at least one anticoagulation advisory of
a plurality of anticoagulation advisories and the graphical user
interface may be configured to depict an anticoagulation advisory
region. The computing apparatus may be further configured to
execute or the method may further include displaying the at least
one preset anticoagulation value for the at least one
anticoagulation advisory of the plurality of anticoagulation
advisories of the selected profile in an anticoagulation advisory
region on the graphical user interface and allowing a user to use
the input apparatus to adjust the at least one preset
anticoagulation value of at least one anticoagulation advisory of
the plurality of anticoagulation advisories of the selected profile
using the anticoagulation advisory region of the graphical user
interface.
[0015] One exemplary extracorporeal blood treatment system may
include display apparatus, input apparatus, and computing
apparatus. The display apparatus may include a graphical user
interface, where the graphical user interface may be configured to
depict a profile identifier region, a therapy type region, and a
therapy set region. The input apparatus (e.g., a touch screen,
etc.) may be configured to allow a user to create a profile
identifier using the profile identifier region of the graphical
user interface, to select a therapy type using the therapy type
region of the graphical user interface, and to select a therapy set
using the therapy set region of the graphical user interface. The
computing apparatus may be operatively coupled to the display
apparatus and the input apparatus and may be configured to store a
plurality of profiles. Each profile of the plurality of profiles
may include an identifier, at least a preset therapy type of a
plurality of different therapy types (e.g., SCUF, CVVH, CVVHD,
CVVHDF, TPE, HP, MARS, and carbon dioxide removal), and a preset
therapy set of a plurality of different therapy sets. The computing
apparatus may be further configured to display a profile identifier
region, a therapy type region and a therapy set region on the
graphical user interface and allow a user to use the input
apparatus to enter an identifier for a new profile of the plurality
of profiles using the profile identifier region, to select a
therapy type of the plurality of different therapy types to be the
preset therapy type of the new profile using the therapy type
region of the graphical user interface, and to select a therapy set
of the plurality of different therapy sets to be the preset therapy
set of the new profile using the therapy set region of the
graphical user interface. The computing apparatus may be further
configured to allow a user to save the new profile into the
plurality of stored profiles.
[0016] One exemplary method for an extracorporeal blood treatment
system may include providing a graphical user interface that may
include a profile identifier region, a therapy type region, and a
therapy set region and providing an input apparatus (e.g., a touch
screen, etc.) configured to allow a user to create or edit a
profile identifier using the profile identifier region of the
graphical user interface, to select a therapy type using the
therapy type region of the graphical user interface, and to select
a therapy set using the therapy set region of the graphical user
interface. The exemplary method may further include storing a
plurality of profiles, where each profile of the plurality of
profiles may include an identifier, at least a preset therapy type
of a plurality of different therapy types (e.g., SCUF, CVVH, CVVHD,
CVVHDF, TPE, HP, MARS, and carbon dioxide removal), and a preset
therapy set of a plurality of different therapy sets. The exemplary
method may further include allowing a user to use the input
apparatus to enter an identifier for a new profile of the plurality
of profiles using the profile identifier region of the graphical
user interface, to select a therapy type of the plurality of
different therapy types to be the preset therapy type of the new
profile using the therapy type region of the graphical user
interface, and to select a therapy set of the plurality of
different therapy sets to be the preset therapy set of the new
profile using the therapy set region of the graphical user
interface, and allowing a user to save the new profile into the
plurality of stored profiles.
[0017] One exemplary extracorporeal blood treatment system may
include display apparatus, input apparatus, and a computing
apparatus. The display apparatus may include a graphical user
interface, where the graphical user interface may be configured to
depict a profile identifier region, a profile selection region, a
therapy type region, and a therapy set region. The input apparatus
(e.g., a touch screen, etc.) may be configured to allow a user to
edit a profile identifier using the profile identifier region of
the graphical user interface, to select a profile using the profile
selection region, to select a therapy type using the therapy type
region of the graphical user interface, and to select a therapy set
using the therapy set region of the graphical user interface. The
computing apparatus may be operatively coupled to the display
apparatus and the input apparatus and may be configured to store a
plurality of profiles. Each profile of the plurality of profiles
may include an identifier, at least a preset therapy type of a
plurality of different therapy types (e.g., SCUF, CVVH, CVVHD,
CVVHDF, TPE, HP, MARS, and carbon dioxide removal), and a preset
therapy set of a plurality of different therapy sets. The computing
apparatus may be further configured to display a profile identifier
region, a profile selection region, a therapy type region, and a
therapy set region on the graphical user interface, allow a user to
use the input apparatus to select a profile of the plurality of
profiles using the profile selection region of the graphical user
interface, display on the graphical user interface the identifier
of the selected profile in the profile identifier region, the
preset therapy type of the selected profile in the therapy type
region, and the preset therapy set of the selected profile in the
therapy set region, allow a user to use the input apparatus to
modify at least one of the preset therapy type of the selected
profile to a different therapy type of the plurality of different
therapy types using the therapy type region of the graphical user
interface and the preset therapy set of the selected profile to a
different therapy set of the plurality of different therapy sets
using the therapy set region of the graphical user interface, and
allow a user to save the modified profile into the plurality of
stored profiles.
[0018] One exemplary method for an extracorporeal blood treatment
system may include providing a graphical user interface including a
profile identifier region, a profile selection region, a therapy
type region, and a therapy set region, providing an input apparatus
(e.g., a touch screen, etc.) configured to allow a user to create
or edit a profile identifier using the profile identifier region of
the graphical user interface, to select a therapy type using the
therapy type region of the graphical user interface, and to select
a therapy set using the therapy set region of the graphical user
interface. The exemplary method may further include storing a
plurality of profiles, where each profile of the plurality of
profiles may include an identifier, at least a preset therapy type
of a plurality of different therapy types (e.g., SCUF, CVVH, CVVHD,
CVVHDF, TPE, HP, MARS, and carbon dioxide removal), and a preset
therapy set of a plurality of different therapy sets. The exemplary
method may further include displaying a profile identifier region,
a profile selection region, a therapy type region, and a therapy
set region on the graphical user interface, allowing a user to use
the input apparatus to select a profile of the plurality of
profiles using the profile selection region of the graphical user
interface, and displaying on the graphical user interface the
identifier of the selected profile in the profile identifier
region, the preset therapy type of the selected profile in the
therapy region, and the preset therapy set of the selected profile
in the therapy set region. The exemplary method may further include
allowing a user to use the input apparatus to modify at least one
of the preset therapy type of the selected profile to a different
therapy type of the plurality of different therapy types using the
therapy type region of the graphical user interface and the preset
therapy set of the selected profile to a different therapy set of
the plurality of different therapy sets using the therapy set
region of the graphical user interface and allowing a user to save
the modified profile into the plurality of stored profiles.
[0019] In one or more embodiments, the graphical user interface may
be further configured to depict an anticoagulation region, and each
profile of the plurality of profiles may further include a preset
anticoagulation type of a plurality of different types of
anticoagulation. The computing apparatus may be further configured
to execute or the method may further include displaying an
anticoagulation region on the graphical user interface and allowing
a user to use the input apparatus to select an anticoagulation type
to be the preset anticoagulation type of the new or the selected
profile using the anticoagulation region of the graphical user
interface. In at least one embodiment, the computing apparatus may
be further configured to execute or the method may further include
allowing a user to use the input apparatus to modify the identifier
of the new or the selected profile using the profile identifier
region. In at least one embodiment, the computing apparatus may be
further configured to execute or the method may further include
allowing a user to save the new profile or the modified profile
into the plurality of stored profiles if at least a therapy type
and a therapy set has been selected.
[0020] In one or more embodiments, each profile of the plurality of
profiles may further include a preset value for at least one flow
rate of a plurality of flow rates, and the graphical user interface
may be further configured to depict a flow rate region. The
computing apparatus may be further configured to execute or the
method may further include displaying a flow rate region on the
graphical user interface and allowing a user to use the input
apparatus to adjust the preset value of the at least one flow rate
of the new or the selected profile using the flow rate region of
the graphical user interface. In at least one embodiment, the
computing apparatus may be further configured to execute or the
method may further include displaying on the graphical user
interface an indication proximate the adjusted preset value of the
at least one flow rate in the flow rate region.
[0021] In one or more embodiments, each profile of the plurality of
profiles may further include at least one preset alarm value for at
least one alarm limit of a plurality of alarm limits, and the
graphical user interface may be further configured to depict an
alarm region. The computing apparatus may be further configured to
execute or the method may further include displaying an alarm
region on the graphical user interface and allowing a user to use
the input apparatus to adjust at least one preset alarm value of
the plurality of alarm limits of the new or the selected profile
using the alarm region of the graphical user interface.
[0022] In one or more embodiments, each profile of the plurality of
profiles may further include at least one preset anticoagulation
value for at least one anticoagulation advisory of a plurality of
anticoagulation advisories, and the graphical user interface may be
further configured to depict an anticoagulation advisory region.
The computing apparatus may be further configured to execute or the
method may further include displaying an anticoagulation advisory
region on the graphical user interface and an allowing a user to
use the input apparatus to adjust at least one preset
anticoagulation value of the plurality of the plurality
anticoagulation advisories of the new or the selected profile using
the anticoagulation advisory region of the graphical user
interface.
[0023] In one or more embodiments, the computing apparatus may be
further configured to execute or the method may further include
allowing a user to use the input apparatus to transfer at least one
profile of the plurality of profiles to an external device. In one
or more embodiments, the graphical user interface may be further
configured to depict a profile selection region that may include a
list of the identifiers of the plurality of profiles, and the
computing apparatus may be further configured to execute or the
method may further include displaying a profile selection region on
the graphical user interface and allowing a user to use the input
apparatus to select a profile of the plurality of profiles using
the profile selection region of the graphical user interface. In at
least one embodiment, the plurality of profiles may include at
least one protected profile, and at least one of the identifier,
preset therapy type, and preset therapy set of the at least one
protected profile may not be modifiable by a user.
[0024] One exemplary extracorporeal blood treatment system may
include display apparatus, input apparatus, and computing
apparatus. The display apparatus may include a graphical user
interface, where the graphical user interface may be configured to
depict a profile selection interface and a profile
creation/modification interface. The input apparatus may be
configured to allow a user to select, create, and modify one or
more profiles. The computing apparatus may be operatively coupled
to the display apparatus and the input apparatus, and may be
configured to store a plurality of profiles, where each profile of
the plurality of profiles may include an identifier, at least a
preset therapy type of a plurality of different therapy types, and
a preset therapy set of a plurality of different therapy sets. The
computing apparatus may be further configured to display on the
graphical user interface a profile selection interface configured
to allow a user to select a profile for use in a treatment and
display on the graphical user interface a profile
creation/modification interface configured to allow a user to
modify one or more profiles of the plurality of profiles and/or to
allow a user to create one or more profiles to be stored in the
plurality of profiles. In at least one embodiment, the profile
selection interface and the profile creation/modification interface
may not be displayed at the same time.
[0025] One exemplary method for an extracorporeal blood treatment
system may include providing a graphical user interface, where the
graphical user interface may be configured to depict a profile
selection interface and a profile creation/modification interface,
providing an input apparatus configured to allow a user to select,
create, and modify one or more profiles, and storing a plurality of
profiles, where each profile of the plurality of profiles may
include an identifier, at least a preset therapy type of a
plurality of different therapy types, and a preset therapy set of a
plurality of different therapy sets. The exemplary method may
further include displaying on the graphical user interface a
profile selection interface configured to allow a user to select a
profile for use in a treatment and displaying on the graphical user
interface a profile creation/modification interface configured to
allow a user to modify one or more profiles of the plurality of
profiles and/or to allow a user to create one or more profiles to
be stored in the plurality of profiles. In at least one embodiment,
the profile selection interface and the profile
creation/modification interface may not be displayed at the same
time.
[0026] The above summary of the present disclosure is not intended
to describe each embodiment or every implementation thereof.
Advantages, together with a more complete understanding of the
present disclosure, will become apparent and appreciated by
referring to the following detailed description and claims taken in
conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWING
[0027] FIG. 1 is a block diagram of an exemplary extracorporeal
blood treatment system including input apparatus and display
apparatus that may utilize the user interfaces and methods
described herein.
[0028] FIG. 2 is a perspective illustration of an exemplary fluid
processing system that may include a graphical user interface as
described herein.
[0029] FIG. 3 is a front view of a portion of the exemplary fluid
processing system shown in FIG. 2.
[0030] FIGS. 4-12 are screenshots of graphical user interfaces for
use in selecting and/or modifying treatment profiles in
extracorporeal blood treatment systems, for example, such as shown
generally in FIGS. 1-3.
[0031] FIGS. 13-17 are screenshots of graphical user interfaces for
use in creating and/or modifying treatment profiles in
extracorporeal blood treatment systems, for example, such as shown
generally in FIGS. 1-3.
[0032] FIG. 18 is a screenshot of a graphical user interface for
use in transferring treatment protocols to and from extracorporeal
blood treatment systems, for example, such as shown generally in
FIGS. 1-3.
DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
[0033] In the following detailed description of illustrative
embodiments, reference is made to the accompanying figures of the
drawing which form a part hereof, and in which are shown, by way of
illustration, specific embodiments which may be practiced. It is to
be understood that other embodiments may be utilized and structural
changes may be made without departing from (e.g., still falling
within) the scope of the disclosure presented hereby.
[0034] Exemplary systems and methods of selecting, modifying, and
creating treatment profiles for use in an extracorporeal blood
treatment shall be described with reference to FIGS. 1-18. As used
herein, a treatment profile, or a profile for short, may be defined
as a set of preset, or predefined, settings and values for an
extracorporeal blood treatment. A profile may include one or more
of the following: an identifier, a preset therapy type, a preset
therapy set (e.g., including filter set, tubing set, etc.), a
preset anticoagulation type, one or more preset flow rates, one or
more preset alarm limits, one or more preset anticoagulation
values, a patient identifier (e.g., ID), one or more replacement
solutions, one or more dialysis solutions, etc. The exemplary
systems and methods may provide, or allow a user to create, a
plurality of different treatment profiles, each including at least
one different setting or value from the next. When initiating, or
preparing, an extracorporeal blood treatment, a user may select a
profile and the preset settings of the selected profile may be
loaded into the extracorporeal blood treatment system, which may
expedite the setup process and also limit errors, e.g., input
errors, etc.
[0035] An exemplary extracorporeal blood treatment system 10
depicted in FIG. 1 may be used to execute the exemplary methods
and/or processes described herein. In at least one embodiment, the
system 10 may be a machine for the extracorporeal treatment of
blood. The system 10 could, for example, alternatively be a blood
processing device or a blood component preparation device or other
medical apparatus for fluid delivery/collection.
[0036] As shown, the exemplary extracorporeal treatment system 10
includes computing apparatus 12. The computing apparatus 12 may be
configured to receive input from input apparatus 20 and transmit
output to display apparatus 22. Further, the computing apparatus 12
may include data storage 14. Data storage 14 may allow for access
to processing programs or routines 16 and one or more other types
of data 18 that may be employed to carry out exemplary methods
and/or processes for use in setting up (e.g., preparing for,
configuring the system for, etc.) and performing extracorporeal
blood treatment. For example, the computing apparatus 12 may be
configured to allow a user to select a treatment profile using the
input apparatus 20 (e.g., based on input from the user) and display
apparatus 22 to configure, or set up, the system 10 to perform
extracorporeal blood treatment according to the selected treatment
profile (e.g., which will be described further herein with respect
to FIGS. 4-12). Further, for example, the computing apparatus 12
may be configured to allow a user to create and/or modify one or
more treatment profiles using the input apparatus 20 and display
apparatus 22 (e.g., which will be described further herein with
respect to FIGS. 13-18). Still further, for example, the computing
apparatus 12 may be configured to allow a user to save a profile
that includes a patient identifier, or ID, to another system or
external device for later retrieval (e.g., when an entered patient
identifier matches that of the saved profile).
[0037] The computing apparatus 12 may be operatively coupled to the
input apparatus 20 and the display apparatus 22 to, e.g., transmit
data to and from each of the input apparatus 20 and the display
apparatus 22. For example, the computing apparatus 12 may be
electrically coupled to each of the input apparatus 20 and the
display apparatus 22 using, e.g., analog electrical connections,
digital electrical connections, wireless connections, bus-based
connections, etc. As described further herein, a user may provide
input to the input apparatus 20 to manipulate, or modify, one or
more graphical depictions displayed on the display apparatus 22 to
select, create, and/or modify treatment profiles that may be used
to configure the extracorporeal blood treatment system 10.
[0038] Further, various devices and apparatus may be operatively
coupled to the computing apparatus 12 to be used with the computing
apparatus 12 to perform one or more extracorporeal
procedures/treatments as well as the functionality, methods, and/or
logic described herein. As shown, the system 10 may include input
apparatus 20 and display apparatus 22. The input apparatus 20 may
include any apparatus capable of providing input to the computing
apparatus 12 to perform the functionality, methods, and/or logic
described herein. For example, the input apparatus 20 may include a
touchscreen (e.g., capacitive touchscreen, a resistive touchscreen,
a multi-touch touchscreen, etc.), a mouse, a keyboard, a keypad, a
trackball, etc. The input apparatus 20 may allow a user to select,
modify, and/or create profiles when used in conjunction with the
display apparatus 22 (e.g., displaying a graphical user
interface).
[0039] Likewise, the display apparatus 22 may include any apparatus
capable of displaying information to a user, such as a graphical
user interface, etc., to perform the functionality, methods, and/or
logic described herein. For example, the display apparatus 22 may
include a liquid crystal display, an organic light-emitting diode
screen, a touchscreen, a cathode ray tube display, etc. As
described further herein, the display apparatus 22 may be
configured to display a graphical user interface that includes one
or more regions and areas used to select, modify, and/or create
treatment profiles to be used in an extracorporeal blood treatment.
For example, the graphical user interface displayed by the display
apparatus 22 may include, or display, a profile region, a therapy
type region, a therapy set region, a flow rate region, an alarm
region, an anticoagulation region, etc. Each of these regions may
be used by a user to view and/or modify a portion of the treatment
profile being displayed on the graphical user interface of the
display apparatus 22. As used herein, a "region" of a graphical
user interface may be defined as a portion of the graphical user
interface within which information may be displayed or
functionality may be performed. Regions may exist within other
regions, which may be displayed separately or simultaneously. For
example, smaller regions may be located within larger regions,
regions may be located side-by-side, etc. Additionally, as used
herein, an "area" of a graphical user interface may be defined as a
portion of the graphical user interface located with a region that
is smaller than the region it is located within.
[0040] The processing programs or routines 16 may include programs
or routines for performing computational mathematics, matrix
mathematics, standardization algorithms, comparison algorithms, or
any other processing required to implement one or more exemplary
methods and/or processes described herein. Data 18 may include, for
example, treatment data, profile identification data, profiles,
profile data (e.g., preset values and/or settings), user accounts,
anticoagulation sample periods, input/output sample periods,
treatment durations, fluid flows, blood flows, patient identifiers,
fluid periodic rates, solution identifiers, target blood
temperature, CRCs, graphics (e.g., graphical elements, icons,
buttons, windows, dialogs, pull-down menus, graphic areas, graphic
regions, 3D graphics, etc.), graphical user interfaces, results
from one or more processing programs or routines employed according
to the disclosure herein, or any other data that may be necessary
for carrying out the one and/or more processes or methods described
herein.
[0041] In one or more embodiments, the system 10 may be implemented
using one or more computer programs executed on programmable
computers, such as computers that include, for example, processing
capabilities, data storage (e.g., volatile or non-volatile memory
and/or storage elements), input devices, and output devices.
Program code and/or logic described herein may be applied to input
data to perform functionality described herein and generate desired
output information. The output information may be applied as input
to one or more other devices and/or methods as described herein or
as would be applied in a known fashion. In at least one embodiment,
output information may include one or more profiles that may be
saved on a server.
[0042] The program used to implement the methods and/or processes
described herein may be provided using any programmable language,
e.g., a high level procedural and/or object orientated programming
language that is suitable for communicating with a computer system.
Any such programs may, for example, be stored on any suitable
device, e.g., a storage media, that is readable by a general or
special purpose program running on a computer system (e.g.,
including processing apparatus) for configuring and operating the
computer system when the suitable device is read for performing the
procedures described herein. In other words, at least in one
embodiment, the system 10 may be implemented using a computer
readable storage medium, configured with a computer program, where
the storage medium so configured causes the computer to operate in
a specific and predefined manner to perform functions described
herein. Further, in at least one embodiment, the system 10 may be
described as being implemented by logic (e.g., object code) encoded
in one or more non-transitory media that includes code for
execution and when executed by a processor operable to perform
operations such as the methods, processes, and/or functionality
described herein.
[0043] Likewise, the system 10 may be configured at a remote site
(e.g., an application server) that allows access by one or more
users via a remote computer apparatus (e.g., via a web browser),
and allows a user to employ the functionality according to the
present disclosure (e.g., user accesses a graphical user interface
associated with one or more programs to process data).
Additionally, the system 10 may be configured by one or more
servers.
[0044] The computing apparatus 12 may be, for example, any fixed or
mobile computer system (e.g., a controller, a microcontroller, a
personal computer, mini computer, etc.). The exact configuration of
the computing apparatus 12 is not limiting, and essentially any
device capable of providing suitable computing capabilities and
control capabilities (e.g., graphics processing, control of
extracorporeal blood treatment apparatus, etc.) may be used.
[0045] As described herein, a digital file may be any medium (e.g.,
volatile or non-volatile memory such as NVRAM or FLASH, a CD-ROM, a
punch card, magnetic recordable tape, etc.) containing digital bits
(e.g., encoded in binary, trinary, etc.) that may be readable
and/or writeable by computing apparatus 12 described herein. In at
least one embodiment, the digital file may be transferred from a
server and stored in random access memory (RAM).
[0046] Also, as described herein, a file in user-readable format
may be any representation of data (e.g., ASCII text, binary
numbers, hexadecimal numbers, decimal numbers, graphically, etc.)
presentable on any medium (e.g., paper, a display, etc.) readable
and/or understandable by a user.
[0047] In view of the above, it will be readily apparent that the
functionality as described in one or more embodiments according to
the present disclosure may be implemented in any manner as would be
known to one skilled in the art. As such, the computer language,
the computer system, or any other software/hardware which is to be
used to implement the processes described herein shall not be
limiting on the scope of the systems, processes or programs (e.g.,
the functionality provided by such systems, processes or programs)
described herein.
[0048] One will recognize that graphical user interfaces may be
used in conjunction with the embodiments described herein. The
graphical user interfaces may provide various features allowing for
user input thereto, change of input, importation or exportation of
files, or any other features that may be generally suitable for use
with the processes described herein. For example, the graphical
user interfaces may allow default values to be used or may require
entry of certain values, limits, threshold values, or other
pertinent information.
[0049] The methods and/or logic described in this disclosure,
including those attributed to the systems, or various constituent
components, may be implemented, at least in part, in hardware,
software, firmware, or any combination thereof. For example,
various aspects of the techniques may be implemented within one or
more processors, including one or more microprocessors,
microcontrollers, DSPs, ASICs, FPGAs, or any other equivalent
integrated or discrete logic circuitry, as well as any combinations
of such components, or other devices. The term "processor" or
"processing circuitry" may generally refer to any of the foregoing
logic circuitry, alone or in combination with other logic
circuitry, or any other equivalent circuitry.
[0050] Such hardware, software, and/or firmware may be implemented
within the same device or within separate devices to support the
various operations and functions described in this disclosure. In
addition, any of the described components may be implemented
together or separately as discrete but interoperable logic devices.
Depiction of different features, e.g., using block diagrams, etc.,
is intended to highlight different functional aspects and does not
necessarily imply that such features must be realized by separate
hardware or software components. Rather, functionality may be
performed by separate hardware or software components, or
integrated within common or separate hardware or software
components.
[0051] When implemented in software, the functionality ascribed to
the systems, devices and methods described in this disclosure may
be embodied as instructions and/or logic on a computer-readable
medium such as RAM, ROM, NVRAM, EEPROM, FLASH memory, magnetic data
storage media, optical data storage media, or the like. The
instructions and/or logic may be executed by one or more processors
to support one or more aspects of the functionality described in
this disclosure.
[0052] The exemplary systems, and exemplary methods performed, or
used, by such exemplary systems, described herein for the
selection, creation, and/or modification of treatment profiles for
use in extracorporeal blood treatments may be generally referred to
as dialysis systems. The general terms extracorporeal treatment and
dialysis as used herein includes hemodialysis, hemofiltration,
hemodiafiltration, hemoperfusion, liver dialysis, and therapeutic
plasma exchange (TPE), among other similar treatment procedures. In
dialysis generally, blood is taken out of the body and exposed to a
treatment device to separate substances therefrom and/or to add
substances thereto, and is then returned to the body. Although
extracorporeal blood treatment systems capable of performing
general dialysis (as defined above, including TPE, which may
technically be a pheresis procedure) shall be described herein with
reference to the exemplary extracorporeal blood treatment system of
FIGS. 2-3, other systems such as those for infusion of drugs,
performance of continuous renal replacement therapy (CRRT),
extracorporeal membrane oxygenation (ECMO), hemoperfusion, liver
dialysis, apheresis, TPE, etc. may benefit from the systems,
methods, and apparatus described herein and the present disclosure
is not limited to any particular fluid processing system.
[0053] In the perspective and partial front views of FIGS. 2-3, the
exemplary extracorporeal blood treatment system 110 that may use
the graphical user interfaces as described herein generally
includes a blood tubing circuit 112 having first and second tubing
segments 114 and 116 which are both connected to the vascular
system of a patient 118 via access and return devices 117 and 119,
respectively. Devices 117 and 119 may be cannulas, catheters,
winged needles or the like as would be understood by one skilled in
the art. Tubing segments 114 and 116 are also connected to a
filtration or processing unit 120. In dialysis, filtration unit 120
is a dialyzer, which is also often referred to as a filter. In TPE,
it may also be referred to as a plasma filter. In this exemplary
system 110, a peristaltic pump 124 is disposed in operative
association with the first tubing segment 114. Numerous other
component devices of blood circuit 112 are also included as, for
example, pressure sensors 127, 128.
[0054] Also shown in FIGS. 2-3 is the processing fluid or filtrate
side of system 110 which generally includes a processing fluid
circuit 140 having first and second processing fluid tubing
segments 141 and 142. Each of these tubing segments is connected to
the filtration unit 120. In these FIGS. 2-3, a respective fluid
pump 144, 146 is operatively associated with each of these tubing
segments 141 and 142. First tubing segment 141 is also connected to
a processing fluid source (e.g., fluid bag 149), which may include
electrolytes pre-mixed therein. Second tubing segment 142 is
connected to a waste collection device (e.g., a waste container
such as a bag 153). A pressure sensor 154 may also be disposed in
second dialysis fluid tubing segment 142.
[0055] FIGS. 2-3 show a system that is common as a basic model for
numerous dialysis procedures including TPE. Additional fluid lines,
circuits, and components may be added (or deleted) to increase
therapy options. Further, as shown in FIGS. 2-3, the system 110
includes an extracorporeal blood control apparatus 160 that
provides numerous treatment options, which may be controlled and/or
monitored via the control/display screen 161 (e.g., a control
apparatus or controller provided in a system housing 193).
Touch-screen controls may be incorporated herewith and/or other
conventional knobs or buttons (not shown) may be used (e.g.,
graphical user interfaces may be displayed via a touchscreen as
described herein). Other and more detailed information regarding an
example apparatus 160 may be found in U.S. Pat. No. 5,679,245; U.S.
Pat. No. 5,762,805; U.S. Pat. No. 5,776,345; and U.S. Pat. No.
5,910,252; inter alia.
[0056] A general dialysis treatment procedure as performed, for
example, with an apparatus described with reference to FIGS. 2-3
will be generally described for exemplary purposes. First, blood is
removed from the patient 118 via access device 117 and flows
through access line 114 to the filter 120. Filter 120 processes
this blood according to a selected one or more of a number of
extracorporeal blood treatment profiles (e.g., selected and
controlled via screen interface 161 of control apparatus 160) and
then returns the processed or treated blood to the patient 118
through return line 116 and return device 119 inserted in or
otherwise connected to the vascular system of the patient 118. The
blood flow path to and from the patient 118, which includes the
access device 117, the access line 114, the filter 120, as well as
the return line 116 and return device 119 back to the patient,
forms the blood flow circuit 112.
[0057] Pressure sensors may be used to sense various pressures in
the system 110. For example, the pressure sensor 127 may be
connected in the access line 114 and allow the fluid pressure in
the access line 114 to be monitored and the second pressure sensor
128 may be connected in the blood circuit 112 between the first
pump 124 and the blood entrance into the filter 120 and may be used
to detect and monitor the pressure of the blood supplied to the
entrance of the filter 120.
[0058] The system 110 may further include a deaeration chamber 125
in the return line to provide a conveyance path that operates like
a vortex to propel air out of the blood. Post-filter replacement
solution may be added into the deaeration chamber on the top of the
blood to prevent an air/blood interface. A deaeration chamber
monitor line 191 may connect the deaeration chamber 125 to an
internal pressure transducer within the system housing 193 using a
connection apparatus, such as, for example, a return pressure port
129. This enables return pressure monitoring, and removal of air
from the deaeration chamber, if needed. A return clamp 131
connected in the blood circuit 112 selectively allows or terminates
the flow of blood through the blood circuit 112 (e.g., return clamp
131 may be activated whenever air is detected in the blood by
bubble detector 126). Further, a pump 162 may be connected to an
anticoagulant container 164 to deliver anticoagulant through an
anticoagulant line 165 to the blood in tubing segment 114 and a
pump 166 may deliver replacement fluid from a replacement fluid
container or bag 168 through a replacement fluid line 170.
[0059] The secondary flow circuit 140 is also shown in FIGS. 2-3 as
it interacts with filter 120. The secondary flow circuit 140 is
connected to the secondary chamber of filter 120. Matter
extracorporeally removed from the blood is removed from the
secondary chamber of filter 120 through the outlet tubing segment
142 of the secondary flow circuit 140, and matter extracorporeally
added to the blood is moved into filter 120 through inlet tubing
segment 141 of the secondary flow circuit 140. The secondary flow
circuit 140 generally includes the fluid source such as bag 149,
inlet fluid line 141, third peristaltic pump 144, the secondary
chamber of the filter 120, a waste fluid line 142, pressure sensor
154, fourth pump 146, and the waste collection device such as
container 153. The source fluid bag 149 may contain a sterile
processing fluid, generally isotonic to blood, into which blood
impurities will diffuse through the semi-permeable membrane of the
filtration unit 120. The pump 144 is connected in inlet fluid line
141 for delivering processing fluid from the processing fluid
source 149 into an entrance to the filter 120. The waste collection
container 153 is provided to collect or receive matter from the
blood transferred across the semi-permeable membrane in filter 120
and/or to receive the used processing fluid after it has passed
through the filter 120. The fourth pump 146 is connected to the
waste collection line 142 for moving body fluid from the filter 120
into the waste collection container 153. The pressure sensor 154
may also be located in the waste collection line 142 for the
purpose of monitoring the pressure in the secondary chamber of
filter 120. Further, although not shown, additional pumps may be
included in the system 110 to pump materials for such as, e.g.,
calcium solutions, predilutions, etc.
[0060] The filtration unit 120, the flow tubing lines, and the
other components in the primary and secondary flow circuits 112 and
140 described herein (with the exception, for example, of the pumps
and perhaps a few other items) may be formed as an integral,
replaceable unit (e.g., an extracorporeal blood set). This integral
replacement unit may be referred to herein as a "therapy set." An
example of such a therapy set, or integral replaceable unit, is
described in greater detail in U.S. Pat. No. 5,441,636 entitled
Integrated Blood Treatment Fluid Module (see also, U.S. Pat. No.
5,679,245, entitled Retention Device for Extracorporeal Treatment
Apparatus). Any number of therapy sets for use in performing
different therapies may be available depending on the system
configuration.
[0061] As can generally be appreciated from FIGS. 2-3, the
integrated tubing and filter module (identified by the reference
numeral 172) includes the filter 120 and all the tubing and related
components described above which are connectable to apparatus 160.
For example, the filter and tubing may be retained on a plastic
support member 174 which is, in turn, connectable to apparatus 160
(e.g., connectable to the system housing 193 of the apparatus 160).
When in the operative position connected to apparatus 160, flexible
fluid conducting tubing lines to and from the filtration unit 120
are held in operative, pump communicative loops for operative
contact with the peristaltic pumping members of the pumps 124, 144,
146 and 166 to cause the fluid to flow through the primary (blood)
and secondary (processing fluid) circuits 112 and 140. Module 172,
including filter 120 and all the tubing lines and associated flow
components may be disposable after use. The peristaltic pumping
members of pumps 124, 144, 146, and 166 may be fixedly disposed on
apparatus 160 (without the disposable tubing loop components) and
may be re-usable. In general, electrical, mechanical, or
electromechanical components are also fixedly disposed in or on
apparatus 160 (e.g., connectable to the system housing 193 of the
apparatus 160). Examples of such components include the display
screen 161 (e.g., a touchscreen), the bubble detector 126, line
clamps 131 and connection apparatus for coupling to pressure sensor
apparatus used to implement pressure sensors 127, 128, 154.
[0062] Screenshots depicting exemplary graphical user interfaces
for use in selecting and modifying one or more treatment profiles
are depicted in FIGS. 4-12. Such exemplary graphical user
interfaces may be depicted by the display apparatus 22 of the
system 10 described herein with reference to FIG. 1 and/or the
display screen 161 of FIGS. 2-3. Additionally, the graphical user
interfaces described herein may be depicted on a touchscreen, and
in such configuration, the input apparatus would also be the
touchscreen.
[0063] An exemplary graphical user interface 200 is depicted in
FIG. 4 that may be generally used in the setup, or preparation, of
an extracorporeal blood treatment. The graphical user interface 200
may include a step region 201 and a profile region 205. As shown,
the step region 201 is depicted on the left side of the graphical
user interface 200 and the profile region 205 is depicted on the
right side of the graphical user interface 200. The step region 201
may include, or graphically depict, the various steps, or
processes, used to prepare an extracorporeal blood treatment system
for an extracorporeal blood treatment of a patient. As shown, the
step region 201 includes exemplary steps: "01 Patient Information,"
"02 Treatment," "03 Accessories," "04 Set Assembly," "05 Fluids,"
"06 Prime Set," "07 Connect Patient," and "08 Final Check." When a
step has been completed, a checkmark 202 may appear next to the
title of the step in the step region 201. Further, the step that is
presently being executed may be highlighted. As shown in FIG. 4,
the "02 Treatment" step is currently being executed, and as such,
is highlighted 204.
[0064] In the "02 Treatment" step, a user may be allowed to use the
input apparatus (e.g., a touchscreen which may also be the display
apparatus) to select a profile and modify a profile in the profile
region 205. For example, a user may use the input apparatus to
select a profile using a profile identifier region 210 of the
graphical user interface 200. As shown, no profile is presently
selected as indicated by the wording "No Profile Selected" located
in an identifier area 212 of the profile identifier region 210. To
the left of the identifier area 212 of the profile identifier
region 210 is the wording "Profile" to indicate, for example, that
this region is the profile identifier region 210.
[0065] Additionally, a user may not want to select a profile or may
not find a profile that is suitable to be used. In this situation,
no profile is selected using the profile identifier region 210 and
the user may utilize the remainder of the profile region 205 of the
graphical user interface 200 to configure the extracorporeal blood
treatment system for a blood treatment. When no profile as been
selected, the wording "No Profile Selected" may be displayed in the
identifier area 212 of the profile identifier region 210. Further,
as shown in FIG. 4, when a profile is selected, but one or more
parameters and/or settings of the selected profile are modified,
the name of the selected profile may still appear in the identifier
area 212 but the wording "-Modified" may appear next to the name of
the profile in the profile identifier area 212 to indicate that the
identified profile has been modified.
[0066] As described herein, a user may be allowed to use an input
apparatus to select a profile using the profile identifier region
210. For example, a user may select a selection area 214 of the
profile identifier region 210 that may result in the display of a
profile selection region 216 including a list of selectable
profiles 219 from a plurality of available profiles for use in
extracorporeal blood treatment as shown in FIG. 5. As used herein,
when a user "selects" a region or area of the graphical user
interface, it is to be understood that selecting the region or area
may be conducted in many different ways using many different types
of input apparatus. For example, when the input apparatus is a
touch screen, a user may select a region or area by "touching" the
region or area with their finger or using a pointing device such as
a stylus. Further, for example, when the input apparatus is a mouse
or similar pointing device, a user may select a region or area by
locating an arrow or cursor over the desired region or area
"clicking" the region or area. Still further, for example, when the
input apparatus is a series of buttons and/or knobs, a user may
select a region or area by using the buttons and/or knobs to
navigate to the region or area and selecting it by depressing a
button and/or knob.
[0067] As shown, the profile selection region 216 may be a
"pop-over" window (e.g., a graphical element that is located over
the remainder of the graphical user interface 200, which may be
"grayed out" as non-functional until a profile has been selected or
the profile selection process cancelled). The profile selection
region 216 may list the plurality of available, selectable profiles
219 by the name, or identifier, of the plurality of profiles 219.
The identifiers of the profiles 219 may be listed alphanumerically.
Further, the therapy type and the therapy set for each profile may
also be listed adjacent the identifier of each profile located in
the same row as each profile identifier. Still further, the profile
selection region 216 may include graphical elements, or icons,
located in the same row as each profile to indicate what type of
anticoagulation that each profile may include, or to indicate any
other parameter or characteristic of the profile.
[0068] A user may select a profile by selecting the identifier, or
name, of the profile, or any other item located in the same row as
the name of the profile, and subsequently select the accept area,
or button, 220 located in the lower right-hand corner of the
profile selection region 216 to accept the selected profile and
dismiss (e.g., make disappear) the profile selection region 216.
Additionally, if a user does not desire to select a profile (e.g.,
if a user does not see a profile that they want to select), the
user may select the cancel area, or button, 222. Further, the
profiles 219 displayed in the profile selection region 216 may be
sorted by selecting the following column headers: "Alphabetical,"
which will sort the profiles alphabetically from top to bottom,
"Therapy" that will sort the profiles by therapy type, "Set" that
will sort the profiles by therapy set," and "AC" that will sort the
profiles by anticoagulation type.
[0069] If a system includes many treatment profiles, the profiles
may be difficult to look, or browse, through to find a user desired
profile. As such, the exemplary graphical user interface 200 may
include a profile filter to, e.g., limit the amount of profiles
displayed to a user in the profile selection region 216. To
initiate the profile filter, a user may select the "Filter
Profiles" area, or button, 294 located within the profile selection
region 216 that may display a profile filter region including one
or more filters, e.g., characteristics or parameters of profiles by
which the profiles may be filtered. For example, each profile may
further include identification data. Such identification data may
include one or more of prescribing doctor, weight, age, gender
disease state, location, intracellular volume, patient identifier
(ID), body surface area, room numbers, validity period, etc.
[0070] The profile filter region may allow a user to filter the
profiles by using the identification data (e.g., patient
identifier, prescribing doctor, etc.) of the profiles. For
instance, a user may want to only display profiles for a particular
prescribing doctor, and as such, use the profile filter region to
select a particular prescribing doctor. After selecting a
particular doctor in the profile filter region, only the profiles
that include the identification data that has the prescribing
doctor may be displayed in the profile selection region 216. In at
least one embodiment, instead of filtering out the unwanted
profiles, the profile selection region 216 may sort the profiles by
the selected filter. For instance, if a user selects "prescribing
doctor" in the profile filter region, the profile selection region
216 may display the profiles arranged by prescribing doctor.
[0071] In at least one embodiment, a patient identifier may be
entered, or input, (e.g., using a bar code reader) into the system
and a relevant profile may be selected based on the entered patient
identifier. For example, a patient identifier may correspond to at
least one profile (e.g., be included in the profile), and thus when
the patient identifier is inputted, the at least one profile
corresponding the patient identifier may be selected.
[0072] Further, one or more profiles listed in the profile
selection region 216 may be unable to be used, or unacceptable for
use, in the extracorporeal blood treatment system due to, e.g., a
conflict between the solutions, therapy sets, anticoagulation
types, etc. available for use. As such, the one or more profiles
that are unacceptable for use may be "greyed out" in the profile
selection region 216 or not available, or shown, in the profile
selection region 216.
[0073] Although a profile selection region 216 is described and
shown herein to be used to select a profile, other embodiments may
use other processes and/or graphical elements to allow a user to
select a profile. For example, a "pull down" menu may be presented
and used for profile selection. Further, for example, a "pop-up"
window or a new screen may be presented and used for profile
selection.
[0074] As described herein, each treatment profile may include one
or more of a preset therapy type, a preset therapy set, a preset
anticoagulation, and one or more preset flow rates. After a user
has selected an exemplary selected profile 213, the identifier, or
name, of the exemplary selected profile 213 may be displayed in the
identifier area 212 of the profile identifier region 210 (as shown,
"Example Profile Name" but could be another name, or identifier,
such as, e.g., "Doctor-XYZ-Female-200 kgs"), a patient identifier,
and the values and/or characteristics of the exemplary selected
profile 213 may be displayed on the graphical user interface 200 as
shown in FIG. 6 (such names, or identifiers, may be searchable
using another field of the display).
[0075] As shown, the graphical user interface 200 may further
include a therapy type region 230, therapy set region 234, an
anticoagulation region 238, and a flow rate region 242. Although
the profile identifier region 210, the therapy type region 230, the
therapy set region 234, the anticoagulation region 238, and the
flow rate region 242 are all depicted, or displayed, on the
graphical user interface 200 simultaneously or at the same time, it
is to be understood that one or more of these regions may be
depicted, or displayed, on the graphical user interface 200 in any
combination (e.g., only one region may be displayed at a time, two
or more regions may be displayed at a time, etc.). In at least one
embodiment, the profile identifier region 210, the therapy type
region 230, the therapy set region 234, and the anticoagulation
region 238 may be displayed on the graphical user interface 200
without the flow rate region 242, and after the profile identifier
region 210, the therapy type region 230, the therapy set region
234, and the anticoagulation region 238 have been selected,
adjusted, etc., then the flow rate region 242 may be displayed or
depicted on the graphical user interface 200 without the profile
identifier region 210, the therapy type region 230, the therapy set
region 234, and the anticoagulation region 238. After a profile has
been selected such as the exemplary selected profile 213, the
therapy type region 230 may display the preset therapy type of the
exemplary selected profile 213, the therapy set region 234 may
display the preset therapy set of the exemplary selected profile
213, the anticoagulation region 238 may display the preset
anticoagulation of the exemplary selected profile 213, and the flow
rate region 242 may display one or more preset flow rates of the
exemplary selected profile 213. As shown in FIG. 6, the exemplary
selected profile 213 is entitled "Example Profile Name" and
includes a preset therapy type of CVVHDF (which is an acronym for
Continuous Veno Venous Hemodiafiltration), a preset therapy set of
M100, a preset anticoagulation type of Syringe Rx, a preset PBP
(which is an acronym for pre-blood pump) flow rate of 222
milliliters per hour (mL/h), a preset BFR (which is an acronym for
blood flow rate) flow rate of 111 milliliters per minute, a preset
Syr (which is an acronym for syringe) flow rate of 000 mL/h, a
preset PFR (which is an acronym for patient fluid removal) flow
rate of 000 mL/h, and a preset Rep (which is an acronym for
replacement fluid) flow (Post) rate of 111 mL/h Although not shown,
the graphical user interface 200 may further include a blood warmer
target temperature region which, e.g., may also be preset by a
profile.
[0076] After the profile has been selected and the values and/or
settings of the selected profile have been displayed in their
respective regions on the graphical user interface 200, a user may
modify one or more of the preset, or predefined, settings and/or
values for the blood treatment defined by the selected profile 213.
As shown in FIG. 7, a user may modify the therapy type by selecting
the therapy type region 230, e.g., by touching the therapy type
region 230 when using a touch screen. As used herein, "therapy
type" may be defined as the type or kind of therapy to be performed
by the extracorporeal blood treatment system.
[0077] In this embodiment, selecting the therapy type region 230
may display a therapy list area 231 (e.g., a "pull-down" list,
dialog, window, graphic element, etc.) displaying the available
different types of therapy. Although the disclosure herein is not
limited by the therapy types described herein, the available
therapy types may be slow continuous ultrafiltration (SCUF),
continuous veno-venous hemofiltration, (CVVH), continuous
veno-venous hemodialysis (CVVHD), continuous veno-venous
hemodiafiltration (CVVHDF), therapeutic plasma exchange (TPE), HP,
molecular adsorbent recirculating system (MARS), carbon dioxide
removal, etc. After the therapy list area 231 is displayed, a user
may select a therapy type from the therapy list area 231, e.g., by
touching a therapy type in the therapy list area 231 when using a
touchscreen. After the therapy type has been selected, the therapy
list area 231 may be dismissed, or disappear, and the selected
therapy type may be displayed in the therapy type region 230.
[0078] Similar to the therapy type region 230, a user may modify
the therapy set by selecting the therapy set region 234, e.g., by
touching the therapy set region 234 when using a touch screen, as
shown in FIG. 8. In this embodiment, selecting the therapy set
region 234 will display a therapy set list area 235 (e.g., a
pull-down list of therapy sets) displaying the available different
types of therapy sets. As used herein, "therapy set" may be defined
as one or more portions, or parts, of the filtration unit 120, the
flow tubing lines, and the other components in the primary and
secondary flow circuits 112 and 140 described herein with reference
to FIGS. 2-3 (with the exception, for example, of the pumps and
perhaps a few other items) that may be formed as an integral,
replaceable unit (e.g., an extracorporeal blood set).
[0079] Although the disclosure herein is not limited by the therapy
sets described herein, the available therapy sets may include M60,
M100, ST100, TPE1000, ADS 150, M150, ST150, ST60, HF1000, HF1400,
etc. After the therapy set list area 235 has been displayed, a user
may select the therapy set from the therapy set list area 235,
e.g., by touching a therapy set in the therapy set list area 235
when using a touchscreen. After the therapy set has been selected,
the therapy set list area 235 may be dismissed, or may disappear,
and the selected therapy set may be displayed in the therapy set
region 234 as shown in FIG. 9.
[0080] Also similar to the therapy type region 230, a user may
modify the anticoagulation type by selecting the anticoagulation
region 238, e.g., by touching the anticoagulation region 238 when
using a touch screen, as shown in FIG. 9. As used herein, an
"anticoagulation type" may be defined as the type of
anticoagulation used for the treatment (e.g., such as the type of
anticoagulation, whether citrate is to be used, whether calcium is
to be infused, whether heparin is to be used, whether low molecular
weight heparin is to be used, whether prostacyclin is to be used,
etc.). In this embodiment, selecting the anticoagulation region 238
may display an anticoagulation list area 239 (e.g., a pull-down
list, etc.) displaying the available different types of
anticoagulation. Although the disclosure herein is not limited by
the types of anticoagulation described herein, the available types
of anticoagulation as shown in FIG. 9 may be No Anticoagulation,
Syringe Rx, Citrate Bag/CA Syringe, etc. After the list of
available types of anticoagulation have been displayed, a user may
select an anticoagulation type from the anticoagulation list area
239, e.g., by touching the anticoagulation type in the
anticoagulation list area 239 when using a touchscreen. After the
anticoagulation type has been selected, the anticoagulation list
area 239 may be dismissed, or may disappear, and the selected
anticoagulation type may be displayed in the anticoagulation region
238 as shown in FIG. 10.
[0081] Further, one or more preset, or predefined, flow rates of a
selected profile may be adjusted or modified as shown in FIG. 10.
Such one or more flow rates may correspond to the selected profile
and the presets or settings of the selected profile such as therapy
type, therapy set, and anticoagulation type. Although an exemplary
system and method may include flow rates for a plurality of
different solutions, each profile may only include flow rates for a
selected set of solutions, and thus, only the flow rates for a
selected set of solutions may be displayed for a selected profile.
In other words, some solutions may be only depicted if a particular
therapy type, therapy set, and/or anticoagulation type are
selected. For example, in at least one embodiment, some solutions
may only be selected or adjusted if citrate anticoagulation is
being used.
[0082] A user may adjust a specific flow rate by selecting a flow
rate display area for the desired specific flow rate displayed in
the flow rate region 242 (e.g., by touching the specific flow rate
area in the flow rate region 242). As shown in FIG. 10, PBP has
been selected by selecting (e.g., touching) the PBP flow rate
display area 244, and in response to the selection, a flow rate
adjustment area 246 may be displayed proximate the PBP flow rate
display area 244. Although the flow rate adjustment area 246 is
displayed below the PBP flow rate display area 244, it is to be
understood that the flow rate adjustment area 246 may be located
anywhere on the graphical user interface 200 (e.g., as a pop-up
dialog, a pop-over area or window, etc.).
[0083] A user may use the flow rate adjustment area 246 to adjust,
or modify, the flow rate of the selected item. In this embodiment,
the flow rate adjustment area 246 may include a rotary portion 248
that may be used to adjust the flow rate. For example, a user may
select an outer smaller circle 250 of the rotary portion 248 and
drag, or move, the outer smaller circle 250 around a central, inner
circle 252 of the rotary portion 248 similar to a crank or a dial.
Moving the outer smaller circle 250 clockwise around the central
inner circle 252 may increase the flow rate while moving the outer
smaller circle 250 counterclockwise around the central inner circle
252 may decrease the flow rate.
[0084] As the PBP flow rate is adjusted, the PBP flow rate
displayed in the PBP flow rate display area 244 may be updated to
reflect the adjusted value (e.g., the PBP flow rate displayed in
the PBP flow rate display area 244 may change while a user is
adjusting the PBP flow rate using the flow rate adjustment area
246). Further, while a flow rate is being modified, the previous
flow rate (e.g., the flow rate prior to any modification or
adjustment) may also be indicated on the graphical user interface
200. For example, the previous flow rate may be indicated in
smaller text next to the flow rate displayed in the flow rate
display area such as the PBP flow rate display area 244.
[0085] Additionally, the flow rate adjustment area 246 may include
a plus button 254 and a minus button 256 that may be selected by a
user to increment and decrement, respectively, the flow rate.
Further, a range of available flow rates may be indicated by a
lower range number 258 (10 mL/h as shown) located in the upper left
of the flow rate adjustment area 246 and an upper range number 260
(10,000 mL/h as shown) located in the upper left of the flow rate
adjustment area 246. Further, the current flow rate (e.g., the flow
rate being adjusted) may be indicated within the range by line 262
located (proportionally located based on the selected flow rate)
between the upper and lower range numbers 258, 260.
[0086] After a specific flow rate has been adjusted or modified, a
user may proceed to modifying or adjusting another flow rate in a
similar manner or any other displayed setting or parameter. As
shown in FIG. 11, a user has selected the Rep flow rate by
selecting the Rep flow rate display area 264 in the flow rate
region 242, and consequently, a flow rate adjustment area 246 has
been displayed on the graphical user interface 200 proximate (e.g.,
below) the Rep flow rate display area 264.
[0087] Additionally, the selection of a specific flow rate in the
flow rate region 242 may further display additional graphical areas
that may be used to adjust, or modify, one or more parameters
related to the selected specific flow rate. For example, as shown
in FIG. 11, a Pre/Post selection area 266 has been displayed upon
selection of the Rep flow rate. The Pre/Post selection area 266 may
be used to set flow rates for different periods of the blood
treatment time period.
[0088] A user may also adjust one or more preset alarm limits
and/or one or more preset anticoagulation advisory values for a
selected profile. For example, a user may select (e.g., touch,
click, etc.) an "Alarm Limits" area, or button, 268 as shown in
FIG. 11 to display an alarm region 270 as shown in FIG. 12. The
alarm region 270 may display one or more (e.g., a plurality) of
preset alarm limits 272. As used herein, "alarm limits" may be
defined as values of certain monitored parameters that may be used
to initiate, or trigger, one or more alarms. When a monitored
parameter exceeds, or crosses, an alarm limit, an alarm may be
triggered to alert an operator or clinician. As shown, the one or
more preset alarm limits 272 may include "Positive Access Pressure
Warning," "Negative Access Pressure Warning," "Return Pressure
Warning," "Clotting Advisory," TMP Too High Advisory," and "Change
Set Advisory." Each of the alarm limits 272 may be adjusted by
selecting a specific alarm limit which may display an alarm limit
adjustment area (e.g., window, dialog, etc.) that may, e.g., be
similar to the flow rate adjustment area 246.
[0089] Further, for example, a user may select (e.g., touch, click,
etc.) an "Anticoag Advisory" area, or button, 274 as shown in FIG.
11 to display an anticoagulation advisory region that may include
one or more preset anticoagulation advisories such as, e.g., time
to empty, etc. As used herein, an "anticoagulation advisory" may be
defined as a setting, or threshold, to trigger, or initiate an
advisory with respect to anticoagulation used in an extracorporeal
blood treatment. The anticoagulation advisory adjustment region may
appear similar to the alarm region 270 but include anticoagulation
advisories as opposed to alarm limits.
[0090] One or more settings or presets of a treatment profile that
are added or adjusted may conflict with the system being used, the
inventory of the clinic, etc. For example, the system being used
may not be able to support each of the settings or presets of the
treatment profile. Further, for example, the clinic within which
the system is used may not include the inventory to support each of
the settings or presets of the treatment profile. If the treatment
profile is in conflict, the graphical user interface 200 may block
a user from proceed, e.g., by graying out the "Accept" area located
in the lower right of the graphical user interface 200.
Additionally, if the treatment profile is in conflict, the
graphical user interface 200 may display a rationale (e.g., reason
or explanation of why the treatment profile is in conflict) to the
user in a treatment parameter area or box, e.g., as shown in the
bottom of the profile region 205 in FIG. 9. In other words, if a
conflict exists between one or more solutions in the profile and
the solutions of the extracorporeal blood treatment system, then
the profile may not be allowed.
[0091] The computing apparatus 12 of the exemplary extracorporeal
blood treatment system 10 may be further configured to allow a user
to create and/or modify one or more profiles for use in performing
extracorporeal blood treatment, as opposed to selected a treatment
profile already created and stored in the system described herein
with respect to FIGS. 4-12. Screenshots depicting exemplary
graphical user interfaces for use in creating and/or modifying one
or more treatment profiles (e.g., to be stored in the system) are
depicted in FIGS. 13-17. Such exemplary graphical user interfaces
may be depicted by the display apparatus 22 of the system 10
described herein with reference to FIG. 1 and/or the display screen
161 of FIGS. 2-3.
[0092] An exemplary profile creation/modification graphical user
interface 300 that may be used in the creation and/or modification
of one or more profiles is depicted in FIG. 13. To display or
access the profile creation/modification graphical user interface
300, a user may need elevated privileges (e.g., access privileges
for security). For example, a user may need to be "logged on" as a
more privileged user, or power user, such that the profile
creation/modification graphical user interface 300 is available.
Such privileged access to the profile creation/modification
graphical user interface 300 may be designed to stop less
privileged clinicians (e.g., nurses) from being able to create
and/or modify the one or more profiles and to allow only more
privileged clinicians (e.g., doctors) to create and/or modify the
one or more profiles. For example, as shown in FIG. 13, a user may
change their privilege by selecting a privilege region 309. As
shown, the privilege region 309 displays "Administrator," which
indicates that an administrator user (e.g., a user that has
elevated privileges to create and/or modify treatment profiles) is
logged in.
[0093] To navigate to the profile creation/modification graphical
user interface 300, a user may select a "Profiles" area, or button,
290 located within a toolbar region 292 of the exemplary graphical
user interface 200 as shown in FIG. 4, which may prompt the display
of the profile creation/modification graphical user interface 300.
However, any navigational region, or portion, may be used to
display the graphical user interface 300 with the graphical user
interface 200 (e.g., on the same screen at the same time) or
separately from the graphical user interface 200. The profile
creation/modification graphical user interface 300 may include a
profile selection region 302 located on the left side of the
graphical user interface 300 and a profile region 304 located on
the right side of the graphical user interface 300.
[0094] The profile region 304 of the graphical user interface 300
may be similar to the profile region 205 of the graphical user
interface 200. For example, the profile region 304 may include a
profile identifier region 310, a therapy type region 330, a therapy
set region 334, an anticoagulation region 338, a fluid rate region
342, and an "Alarm Limits" area, or button, 368 that may be similar
to the profile identifier region 210, the therapy type region 230,
the therapy set region 234, the anticoagulation region 238, the
fluid rate region 342, and the "Alarm Limits" area, or button, 268,
respectively, of the graphical user interface 200 described herein
with reference to FIGS. 4-12. Although the profile identifier
region 310, the therapy type region 330, the therapy set region
334, the anticoagulation region 338, and the flow rate region 342
are all depicted, or displayed, on the graphical user interface 300
simultaneously or at the same time, it is to be understood that one
or more of these regions may be depicted, or displayed, on the
graphical user interface 300 in any combination (e.g., only one
region may be displayed at a time, two or more regions may be
displayed at a time, etc.). In at least one embodiment, the profile
identifier region 310, the therapy type region 330, the therapy set
region 334, and the anticoagulation region 338 may be displayed on
the graphical user interface 300 without the flow rate region 342,
and after the profile identifier region 310, the therapy type
region 330, the therapy set region 334, and the anticoagulation
region 338 have been selected, adjusted, etc., then the flow rate
region 342 may be displayed or depicted on the graphical user
interface 300 without the profile identifier region 310, the
therapy type region 330, the therapy set region 334, and the
anticoagulation region 338.
[0095] The graphical user interface 300, however, is configured to
allow a user to create one or more treatment profiles and save such
one or more profiles into the system for later use during
preparation of the system for an extracorporeal blood treatment.
Further, the graphical user interface 300 may also be configured to
allow a user to modify one or more already saved profiles and save
the profiles as modified (e.g., with the changes, or modifications,
made to the profile using the graphical user interface 300 and
provided with a different name or identifier).
[0096] To modify an existing profile, a user may select an existing
profile using the profile selection region 302. The profile
selection region 302 may include a list of profiles 306 (e.g.,
listed by name, therapy type, therapy set, disease type, etc.).
When a user selects a profile, the profile may be indicated as
being selected in the graphical user interface and the preset, or
predefined, values for the selected profile may be displayed in the
profile region 304. For example, when the exemplary selected
profile 308 entitled "Custom Treatment Profile 3" has been
selected, it may be highlighted as shown in FIG. 13, and the
preset, or predefined, values for the selected profile 308 may be
displayed in the profile region 304. The selected profile 308 may
then be modified. More specifically, one or more preset values
and/or settings of the selected profile 308 may be changed.
[0097] Further, at least one of the profiles stored on the system
and listed in the profile selection region 302 may be protected
from deletion or modification of one or more settings. In other
words, such protected profiles may not be deleted by a user or one
or more settings may not be modified by a user. For example, at
least one of an identifier, preset therapy type, and preset therapy
set of a protected profile may not be modifiable by a user.
[0098] To create a new profile, a user may select the "Add" area,
or button, 350 located near the bottom of the graphical user
interface 300. As shown in FIG. 14, selection of the "Add" area, or
button, 350 may display a new profile 311, i.e., "(New Treatment
Profile)," in the profile selection region 302 and blank, or
neutral, settings and/or values for the new profile in the profile
region 304. The new profile may then be created. More specifically,
one or more values and/or settings of the new profile may be
selected or set (e.g., filled in, selected from pull-down menus,
etc.).
[0099] To remove a profile, a user may select a profile in the
profile selection region 302 and may select the "Remove" area, or
button, 352 located near the bottom of the graphical user interface
300. In one or more embodiments, the graphical user interface 300
may display a confirmation region such that the user may confirm
that they would like to remove the highlighted profile. The
confirmation region may be, e.g., a pop-up window or dialog.
[0100] The modification of an existing profile and the creation of
a new profile using the graphical user interface 300 may be similar
in that each setting or value for the existing profile and the new
profile may be changed. FIGS. 14-18 depict the creation of a new
profile using the graphical user interface 300. It is to be
understood that a profile may be modified using the same or similar
processes and/or interfaces as shown in FIGS. 14-17 except that
instead of displaying void, or blank, values or settings of the new
profile, the graphical user interface 300 may display the preset,
or predefined, settings of the selected profile to be modified
(e.g., to create a new profile).
[0101] The identifier of the new profile 311 may be modified by
selecting the profile identifier region 310 of the profile region
304. Upon selection of the profile identifier region 310, the
graphical user interface may provide a graphic region or area to
input a new identifier for the new profile 311.
[0102] An exemplary profile identifier modification region 315 is
depicted in FIG. 15. The modification region 315 includes a
touchscreen keyboard configured such that a user may select one or
more letters of the keyboard to input a new identifier in the
profile identifier region 310. As shown, the identifier of the new
profile 311 has been modified to be "Example Profile Name." After a
user has finished modifying the identifier 313 of the new profile
311, the user may select the "Accept" area, or button, 318 located
on the keyboard of the modification region 315, which may dismiss
the modification region 315 from the graphical user interface 300.
Additionally, if a user decides to cancel, or stop, modifying the
identifier, the user may select the "Cancel" area, or button, 319
located on the keyboard of the modification region 315, which may
also dismiss the modification region 315 from the graphical user
interface 300 but without accepting any changes to the profile
identifier 313.
[0103] The therapy type, therapy set, anticoagulation type, and one
or more flow rates of the new profile 311 may be modified (e.g.,
modified from a blank, or null, value or setting) similar to how
the therapy type, therapy set, anticoagulation type, and one or
more flow rates of the selected profile 213 is modified as
described herein with reference to FIGS. 4-12, and as such, the
modification processes and functionality as well as the graphic
regions/areas will not be described further herein in detail. In
other words, the profile region 304 of the graphical user interface
300 may include similar profile modification processes and
functions as well as graphic regions/areas as the graphical user
interface 200 as described herein with reference in FIGS. 4-12.
[0104] As shown in FIG. 16, a user has created a new profile 311
entitled "Example Profile Name" as shown in the profile identifier
region 310. The new profile 311 includes a therapy type of TPE as
shown in the therapy type region 330, a therapy set of TPE1000 as
shown in the therapy set region 334, an anticoagulation type of
Syringe Rx as shown in the anticoagulation region 338, and a PBP
flow rate of 222 ml/h as shown in the flow rate region 342.
[0105] After a new profile has been created or a profile has been
modified, a user may select a "Save" area, or button, 325 of the
graphical user interface 300. In one or more embodiments, to save a
newly-created profile or a modified profile, one or more settings
or values of newly-created or modified profile may need to be set.
For example, each profile may be required to include at least a
therapy type and a therapy set to be saved, and if a newly-created
profile or a presently-modified profile does not include one of a
therapy type and a therapy set, the graphical user interface 300
may not allow a user to save the profile as created or modified. In
at least one embodiment, the graphical user interface may provide
this functionality by not making the "Save" button available to the
user (e.g., by providing no interaction when selected,
"greying-out" the button, etc.) when one of a therapy type and a
therapy set is not preset.
[0106] Additionally, a user may also adjust one or more alarm
limits for the new selected profile 311. For example, a user may
select (e.g., touch, click, etc.) an "Alarm Limits" area, or
button, 368 as shown in FIG. 16 to display an alarm region 370 as
shown in FIG. 17. The alarm region 370 may display one or more
(e.g., a plurality) of alarm limits 372. As shown, the one or more
alarm limits 372 may include "Positive Access Pressure Warning,"
"Negative Access Pressure Warning," "Return Pressure Warning,"
"Clotting Advisory," TMP Too High Advisory," and "Change Set
Advisory." Each of the alarm limits 372 may be adjusted by
selecting a specific alarm limit which may display an alarm limit
adjustment area (e.g., window, dialog, etc.) that may, e.g., be
similar to the flow rate adjustment area 246.
[0107] Filter profile information for use with the profile filter
region described herein with reference to the profile selection
region 216 may be modified or added to a treatment profile using
the graphical user interface 300. For example, a user may select a
treatment profile 306 using the treatment profile selection region
302 and select a filter properties area, or button, 390 as shown in
FIG. 13. Selecting the filter properties area 390 may present a
filter properties input region configured to allow a user to input
identification data for the selected profile such as, e.g.,
prescribing doctor, weight, age, gender, disease state, location,
intracellular volume, etc. Such identification data may then be
used to sort, or filter, the stored profiles when using the profile
selection 216 described herein within reference to FIG. 5.
[0108] Treatment profiles may be transferred to and from exemplary
extracorporeal blood treatment systems, e.g., for storage or
record-keeping purposes, for transfer to another machine, etc. An
exemplary graphical user interface 400 for use in transferring
treatment protocols to and from exemplary extracorporeal blood
treatment systems is depicted in FIG. 18. The graphical user
interface 400 includes a local profile list region 402 and an
external profile list region 404. The local profile list region 402
may be configured to list the plurality of treatment profiles
stored on the extracorporeal blood treatment system. In other
words, the local profile list region 402 shows the treatment
profiles stored locally, or on the system that is displaying the
graphical user interface 400.
[0109] Various information for each displayed, stored profile may
be further shown, or displayed, in the profile list region. As
shown, the identifier of each profile is located in an "ID" column
410, the therapy type of each profile is located in a "Therapy"
column 412, the therapy set of each profile is located in a "Set"
column 414, the anticoagulation type of each profile is located in
a "AC" column 416, and the date that each profile was lasted used
is located in "Date" column 418. Additionally, although the date of
creation for each profile may not be displayed as shown, each
profile may further include its date of creation, and may be
depicted in one or more profile list regions.
[0110] Likewise, the external profile list region 404 may be
configured to list the plurality of treatment profiles stored on an
external device (e.g., external, or separate from, the
extracorporeal blood treatment system) such as, e.g., a memory
card, a Universal Serial Bus memory stick, another extracorporeal
blood treatment system, a computer, etc. that is operatively
connected (e.g., via a network, internet, cloud, servers, etc.) to
the extracorporeal blood treatment system. In other words, the
external profile list region 404 shows the treatment profiles not
stored locally, or on the system that is displaying the graphical
user interface 400, but that are located, for example, on a device
or apparatus that is operatively coupled to the extracorporeal
blood treatment system.
[0111] In at least one embodiment, the extracorporeal blood
treatment system may include a data port such as Universal Serial
Bus (USB) port and a USB memory stick may be coupled to such USB
port for transfer of treatment profiles.
[0112] To transfer one or more profiles from the extracorporeal
blood treatment system to the external device, or vice versa, a
user may select the profiles that they would like to transfer
(e.g., by touching the profiles, by clicking the profiles, etc.)
and then selecting the transfer area, or button, 422 located near
the bottom of the graphical user interface 400. As shown, an arrow
pointing leftward is highlighted within the transfer button 422
indicating the direction of the transfer, e.g., from the
extracorporeal blood treatment system to the external device, from
the external device to the extracorporeal blood treatment system,
etc.
[0113] Additionally, the graphical user interface 400 may further
include an external device selection region 406 configured to allow
a user to select which external device's (e.g., of the external
devices coupled to the system) contents should be displayed in the
external profile list region 404. As shown, the external device is
a "Removable Device" such as a USB memory stick. After the external
device selection region 406 has been selected, another region such
as a window or dialog may appear on the graphical user interface
400 by which a user may select what external device's contents
should be displayed in the external profile list region 404.
[0114] Further, the graphical user interface 400 may also be
configured to transfer other data such as, e.g., historical data,
performance data, settings, processes, etc. to and from the
extracorporeal blood treatment system to an external device. As
shown, a user may select a transfer type region 408 to display
another region such as a window or dialog on the graphical user
interface 400 configured to allow a user to select what type of
data should be shown in the list regions 402, 404. In other words,
the transfer type region 408 may provide a filtering function
configured to only show the selected type of data on the
extracorporeal blood treatment system and the external device while
filtering out the unselected type of data (e.g., filter by
physician). As shown in FIG. 18, the "Treatment Profiles" transfer
type has been selected, and as such, only treatment profiles have
been displayed in each list region 402, 404.
[0115] All patents, patent documents, and references cited herein
are incorporated in their entirety as if each were incorporated
separately. This disclosure has been provided with reference to
illustrative embodiments and is not meant to be construed in a
limiting sense. As described previously, one skilled in the art
will recognize that other various illustrative applications may use
the techniques as described herein to take advantage of the
beneficial characteristics of the apparatus and methods described
herein. Various modifications of the illustrative embodiments, as
well as additional embodiments of the disclosure, will be apparent
upon reference to this description.
* * * * *